NATURE’S SUNSHINE PRODUCTS, INC. Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31)
NATURE’S SUNSHINE PRODUCTS, INC. (NATR) had Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) of $366.00 thousand as of 2013-09-30, per its 10-Q filed 2013-11-08.
Discontinued › Notes › Investments
us-gaap:AvailableforsaleSecuritiesGrossUnrealizedGain · last filed 2013-11-08
- 2013-09-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $366.00K.
- 2013-06-30: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $307.00K.
- 2013-03-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $293.00K.
- 2012-12-31: Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) $258.00K.
| Period end | Available-for-sale Securities, Gross Unrealized Gains (Deprecated 2013-01-31) |
|---|---|
| 2013-09-30 | $366.00K 10-Q · filed 2013-11-08 |
| 2013-06-30 | $307.00K 10-Q · filed 2013-08-09 |
| 2013-03-31 | $293.00K 10-Q · filed 2013-05-09 |
| 2012-12-31 | $258.00K 10-Q · filed 2013-11-08 |
| 2012-09-30 | $276.00K 10-Q · filed 2012-11-06 |
| 2012-06-30 | $248.00K 10-Q · filed 2012-08-03 |
| 2011-12-31 | $210.00K 10-K · filed 2013-03-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| MACROGENICS INC (MGNX) | United States | $0.242B | -20.11 |
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |